The mRNA and protein expression of GDH1 were elevated in luminal A/B (ER+) BC, compared to triple-negative breast cancer (TNBC), but the level of GDH1 in HER2+ tumors remained controversial across different studies.237. Here, GLUD1 is linked to triple-negative breast carcinoma.